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ABSTRACT An emm32.2 invasive group A streptococcus (iGAS) outbreak occurred
in Liverpool from January 2010 to September 2012. This genotype had not previ-
ously been identiﬁed in Liverpool, but was responsible for 32% (14/44) of all iGAS
cases reported during this time period. We performed a case-case comparison of
emm32.2 iGAS cases with non-emm32.2 control iGAS cases identiﬁed in the Liver-
pool population over the same time period to assess patient risk factors for
emm32.2 iGAS infection. The emm32.2 iGAS cases were conﬁned to the adult popu-
lation. We show that homelessness, intravenous drug use, and alcohol abuse predis-
posed patients to emm32.2 iGAS disease; however, no obvious epidemiological link-
age between the patients with emm32.2 iGAS could be identiﬁed. Comparative
whole-genome sequencing analysis of emm32.2 iGAS and non-emm32.2 control iso-
lates was also performed to identify pathogen factors which might have driven the
outbreak. We identiﬁed 19 genes, ﬁve of which had previously been implicated in
virulence, which were present in all of the emm32.2 iGAS isolates but not present in
any of the non-emm32.2 control isolates. We report that a novel emm32.2 genotype
emerged in Liverpool in 2010 and identiﬁed a speciﬁc subset of genes, which could
have allowed this novel emm32.2 genotype to persist in a disadvantaged population
in the region over a 3-year period.
KEYWORDS iGAS, streptococci, Streptococcus pyogenes, epidemiological data, whole-
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Lanceﬁeld group A beta-hemolytic streptococcus (GAS), also called Streptococcuspyogenes, is a frequent commensal of the human oropharynx and also an important
human pathogen, responsible for 750 million infections annually (1). Clinical disease
ranges in severity from mild pharyngitis and impetigo to life-threatening necrotizing
fasciitis (2). GAS disease has been described in all human populations, although certain
groups appear particularly susceptible (3). Other notable features of GAS epidemiology
include the propensity for long-term ﬂuctuations in disease rates, such as the recent
substantial increase in scarlet fever in the United Kingdom in 2013/2014 (4), and the
association with outbreaks. GAS outbreaks are strongly associated with long-term-care
or institutional facilities (5–8) and occur less often within whole communities (9–11).
The introduction of new emm genotypes (12, 13) or the acquisition of prophages
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harboring virulence genes by previously circulating GAS are the primary mechanisms
underpinning these outbreaks (14–16).
The antiphagocytic M surface protein, encoded by the emm gene, is a major
virulence factor and also an epidemiological marker, which is used to type GAS isolates
(3); over 230 emm types have been described to date (4). In addition to the M protein,
virulence is determined by adhesion proteins, by toxin production, and by the absence
or presence of a capsule, and is inﬂuenced by host factors (5). GAS is also typed based
on multilocus sequence typing (MLST); 651 MLST variants have been reported to date
(17).
Here, we describe the emergence and persistence of a novel GAS emm type,
emm32.2, in Liverpool, Merseyside, United Kingdom. The emm32.2 genotype was
unusual in that it showed an association with repeated invasive GAS (iGAS) cases over
a period of 3 years, almost wholly conﬁned to Liverpool and to an adult population
without a clear epidemiological linkage. We utilized comparative genomic analyses of
the emm32.2 outbreak isolates with other invasive and noninvasive isolates, recovered
from individuals within the same community and same time frame, to identify genomic
features unique to the emm32.2 type which may have driven the ability of this emm
type to emerge and persist within the population.
RESULTS
Emergence of emm32.2 iGAS in Liverpool. Fourteen cases of emm32.2 iGAS were
recorded in Liverpool (n  12) and the wider Merseyside area (n  2) between January
2010 and September 2012, all conﬁned to the adult population with a median age of
47 years (range, 18 to 65 years). Over the study period, emm32.2 accounted for 32%
(14/44) of all iGAS cases reported in Liverpool. Prior to January 2010, emm32.2 iGAS had
not been reported in Liverpool and only three emm32.2 iGAS cases had ever been
reported in the United Kingdom to the Respiratory and Vaccine Preventable Bacteria
Reference Unit (RVPBRU) previously; one in Birmingham and two in Glasgow (R.
Vivancos, unpublished data). No emm32.2 cases have subsequently been reported to
the RVPBRU since September 2012. Figure 1 shows a histogram of the iGAS cases
during the study period.
Case-case comparison. The case fatality rate associated with emm32.2 iGAS out-
break cases did not differ from the case fatality rate of the non-emm32.2 iGAS cases
reported from the Liverpool population during the same time period (25% versus 10%,
respectively; P 0.374). We performed a case-case comparison study to investigate risk
factors associated with the emm32.2 iGAS outbreak cases (Table 1). Only emm32.2 iGAS
cases (n  12) from Liverpool residents were included in the epidemiological investi-
gations; emm32.2 iGAS cases (n  2) from the two wider Merseyside area residents
were not included as these patients could not be contacted for follow-up. The outbreak
cases were conﬁned to the adult population; of the 30 control cases, 25 (83%) were
FIG 1 Histogram plot of all iGAS cases in Liverpool from January 2010 to December 2012 reported to the Respiratory and Vaccine Preventable
Bacteria Reference Unit of Public Health England. Over this time period, 14 outbreak emm32.2 outbreak iGAS cases were reported.
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reported in the adult population, the remaining ﬁve (17%) were reported in children.
However, the outbreak cases did not differ signiﬁcantly in age or sex from the control
patients with non-emm32.2 iGAS. Furthermore, patient interview data collected by
Public Health England (PHE) suggested that the frequency of recent travel was low in
both the cases and the controls with no statistically signiﬁcant difference of travel
between these two groups (8% versus 0%, respectively; P  2.0). Of interest, however,
outbreak cases were more likely to occur in the homeless (30% versus 0%, respectively;
odds ratio [OR], 1.59  108; P  0.001), intravenous drug users (50% versus 5%,
respectively; odds ratio [OR], 10; P  0.009) and alcohol abusers (42% versus 5%,
respectively; OR, 14; P  0.002) relative to the control cases. A multivariate logistic
regression model identiﬁed both homelessness and alcohol abuse as independent
factors (Akaike information criteria [AIC], 37.7), yet these factors only explain about 50%
of the outbreak cases. The geographical distribution of outbreak cases showed areas of
higher concentration, whereas that of controls was more disperse; however, further
interview of cases found no common epidemiological link between the outbreak cases.
In silico genotyping. We sequenced 48 GAS isolates, including all 14 emm32.2
outbreak isolates, 15 non-emm32.2 iGAS isolates, and 19 noninvasive isolates that were
not part of the outbreak. Following whole-genome sequencing, in silico emm typing
and multilocus sequence typing were performed on each isolate (Fig. 2; see also Table
S1 in the supplemental material). Fourteen different sequence types (ST) were identi-
ﬁed in the data set. In concordance with the RVPBRU molecular typing results, in silico
typing conﬁrmed all of the outbreak iGAS cases as emm32.2. The emm32.2 isolates were
further characterized as ST386. There are only ﬁve previous reports of ST386 in the
pubmlst.org database, all from iGAS cases in the Czech Republic between 2003 and
2008 (http://pubmlst.org/spyogenes/). The nonoutbreak isolates consisted of 12 differ-
ent emm types and 12 different STs.
Virulence genes unique to the outbreak isolates. Following orthologous cluster-
ing of genes identiﬁed in the annotated genomes, the genes from all isolates were
divided into two groups: orthologous genes shared by all isolates (core genes) and
those not shared by all isolates (accessory genes). We identiﬁed 5,971 orthologous
clusters in the data set, of which 1,294 represented core genes. A phylogeny based on
TABLE 1 Case-case comparison of clinical and demographic characteristics associated
with iGAS casesa
Factor
No. of cases (%)
Odds ratio
(conﬁdence interval) P value
Outbreak
(n  12)
Control
(n  30)
Age (years) 0.132
1 0 (0) 1 (3) 1
1–9 0 (0) 2 (7) 1 (0–∞)
10–19 1 (8)b 2 (7) 2.13  107 (0–∞)
20–29 1 (8) 3 (10) 1.42  107 (0–∞)
30–39 1 (8) 1 (3) 4.25  107 (0–∞)
40–49 4 (34) 3 (10) 5.67  107 (0–∞)
50–59 4 (34) 4 (13) 4.25  107 (0–∞)
60 1 (8) 14 (47) 3.04  106 (0–∞)
Male sex 7 (58) 15 (50) 1.4 (0.36–5.41) 0.624
Travel 1 (8) 0 (0) 2.45  1014 (0–∞) 0.202
Deceased 3 (25) 4 (13) 2.17 (0.4–11.6) 0.374
Pregnant 0 (0) 3 (10) 0 (0–∞) 0.146
IVDUc 6 (50) 2 (7) 14 (2.25–87.02) 0.002
Homeless 4 (34) 0 (0) 1.59  108 (0–∞) 0.001
Alcohol 5 (42) 2 (7) 10 (1.59–62.78) 0.009
Inﬂuenza-like illness 0 (0) 2 (7) 0 (0–∞) 0.239
aOutbreak (emm32.2) and nonoutbreak control cases belonging to multiple emm types that were reported in
Liverpool, United Kingdom, between January 2010 and December 2012.
bThis case was in an 18-year-old.
cIVDU, intravenous drug use.
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single nucleotide polymorphism (SNP) differences between the concatenated core
genes is presented in Fig. 2. Within the phylogeny, the emergent emm32.2 outbreak
isolates form a distinct clade, clearly separated from the nonoutbreak isolates. The
phylogeny indicates that the emm32.2 isolates are genetically distinct from the other
isolates circulating within the same population during the same time period. To identify
genes that may have driven the outbreak, we compared the accessory gene content of
the outbreak versus the control isolates. We identiﬁed 19 accessory genes that were
present in all of the outbreak isolates but completely absent in the rest of the data set
(Table 2 and Fig. 2; see also Table S1). Five of the accessory genes unique to emm32.2
could be assigned a deﬁnitive function and have previously been implicated in bacterial
virulence, including an Mga-like regulatory protein, an Myr positive regulator, LepA,
trypsin-resistant surface protein T6, and a hyaluronidase (HylP) (Table 2).
Prophage acquisition. Previous studies have documented that the acquisition of
bacteriophages carrying virulence genes has driven GAS outbreaks (14–16). Therefore,
we next investigated the location of the emm32.2 unique genes within the assembled
genomes to assess if any were associated with a bacteriophage. The study isolates
encoded between one and three intact bacteriophages, ranging in size from 9,978 bp
to 55,428bp. However, no bacteriophage was shared by all of, or was unique to, the
emm32.2 isolates (Fig. 3). Furthermore, none of the emm32.2 unique genes corre-
sponded to regions of the genome where bacteriophages were identiﬁed. This sug-
gests that prophage acquisition did not drive the emm32.2 outbreak.
Superantigens and antibiotic resistance. We screened the sequenced isolates for
the distribution of known GAS toxins to assess if speciﬁc superantigen proﬁles were
unique to the emm32.2 isolates. Of the 22 superantigens that we screened for, none
FIG 2 Maximum likelihood phylogeny of the 48 GAS isolates based on core genome SNPs. Each branch is annotated with the isolate source
followed by the in silico emm type. R, the GAS reference sequence Streptococcus pyogenes HKU16; C, control iGAS cases; N, control noninvasive
isolates; and O, outbreak emm32.2 iGAS cases. (Right) The absence (gray) or presence (black) of accessory genes in each strain in no particular
order. An expanded version of this ﬁgure, showing the gene names is presented in Table S1 in the supplemental material.
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were unique to the emm32.2 population. All of the toxins identiﬁed in the emm32.2
population were also present in a large proportion of the control isolates (Fig. 3). No
antibiotic susceptibility data were available from the reference laboratory; therefore, we
next screened the sequenced isolates for the distribution of antibiotic resistance genes.
No antibiotic resistance gene proﬁles were unique to the emm32.2 isolates relative to
the nonoutbreak isolates (Fig. 3). This indicates the emm32.2 outbreak was not driven
by the acquisition of superantigens or antibiotic resistance mechanisms.
DISCUSSION
We have shown that an outbreak of emm32.2 iGAS cases in Liverpool (between
January 2010 and September 2012) was conﬁned to the adult population in a small
geographical area. Whole-genome sequencing of outbreak clones is a powerful tool for
characterizing the biological properties, for rapidly identifying the virulence factors, and
for expanding our understanding of the pathogenesis of the organisms under inves-
tigation. Through high-resolution core and accessory genome analyses, we have dem-
onstrated that the emergent emm32.2 isolates harbored a combination of 19 genes not
identiﬁed in other isolates circulating in the same community during the same time
frame. A subset of the 19 genes have well-characterized roles in virulence and patho-
genesis, namely, genes encoding an Mga-like regulatory protein, an Myr positive
regulator, LepA, trypsin-resistant surface protein T6, and a hyaluronidase (HylP). The
Mga DNA binding protein has been shown to induce the expression of a number of
important virulence factors (18). Natural variation leading to a 12-bp deletion within the
Mga promoter has been shown to result in a signiﬁcantly decreased virulence of GAS
in an in vivo model (19). Nonsynonymous SNPs resulting in an amino acid change at
position 201 of the translated Mga protein were found to have occurred multiple times
in the evolutionary history of emm59 iGAS during an epidemic outbreak in Canada (20).
The presence of an alternative Mga regulator within the outbreak isolates could lead to
an increased expression of virulence factors within the outbreak isolates and may, in
part, explain the increased mortality rate observed in the outbreak cases compared
with that in the controls. The canonical Myr regulator protein is known to contribute to
the resistance to phagocytosis through controlling the transcription of the antiphago-
TABLE 2 Predicted functions of 19 accessory genes unique to emm32.2 outbreak isolatesa
Cluster
no.b
Representative
sequence IDc Most signiﬁcant BLAST matchc
Query
coverage (%) E value
Identity
(%) Accession no.
183 101008_01052 Endodeoxyribonuclease/NUMOD4 motif protein 100 1.00E131 100 WP_011017973.1
1734 101008_00230 GTP-binding protein LepA (SipA) 100 4.00E76 100 WP_002984850.1
1882 101008_01097 HNH endonuclease 100 3.00E86 100 WP_032460877.1
1847 101008_01057 Hyaluronidase protein (HylP) 100 0 99 WP_023079488.1
1842 101008_01051 Hypothetical protein 100 1.00E136 100 WP_002991560.1
1925 101008_01398 Hypothetical protein 98 4.00E50 100 EFM32866.1
1921 101008_01377 M protein, trans-acting regulator (Mga) 95 4.00E160 99 KGE57367.1
1922 101008_01378 M protein, Myr positive regulator 100 8.00E38 100 KGE57368.1
1919 101008_01354 Short-chain fatty acid transporter domain protein 100 5.00E92 100 WP_021340353.1
1917 101008_01349 Trypsin-resistant surface protein T6 100 0 100 WP_038433629.1
1923 101008_01380 Protein precursor 100 0 85 WP_063629327.1
1914 101008_01346 —d — — — —
1920 101008_01376 — — — — —
1885 101008_01100 — — — — —
1881 101008_01096 — — — — —
1785 101008_00610 — — — — —
1784 101008_00609 — — — — —
1840 101008_01049 — — — — —
1908 101008_01284 — — — — —
aPredicted functions based on a comparison of the amino acid sequence to the NCBI BLAST database.
bAccessory genome clusters containing the nucleotide sequences and translated amino acid sequences of the emm32.2 unique genes are available at https://datahub
.io/dataset/liverpool-gas.
cRepresentative sequence identiﬁer (ID) represents the speciﬁc amino acid sequence from each cluster that was used as an input query sequence for comparison to
the NCBI database.
d—, no match was available in the NCBI BLAST database.
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cytic M protein. Therefore, the presence of the Myr protein in the emm32.2 isolates
likely contributed to the emergence of the emm32.2 clone in the Liverpool population
by allowing it to evade the host immune response (21). LepA (also known as SipA), a
putative signal peptidase essential for pilus assembly, and the tee6 gene, encoding the
pilus shaft protein T6, were also unique to the emm32.2 isolates. The T6 protein forms
part of the ﬁbronectin-binding protein, collagen-binding protein, and trypsin-resistant
antigen (FCT) type 1 pilus (22). Pilus structures are an important virulence factor in
streptococci and play key roles in tissue adherence, bioﬁlm formation, and extracellular
translocation (23). Deletion of tee6 has been shown to compromise the ability to form
bioﬁlms in the majority of the GAS isolates studied (22). The assembly of the type 1
pilus in the emm32.2 isolates is likely to contribute to the virulence of the outbreak
isolates. Finally, unique to the emm32.2 isolates was the hylP gene encoding a hyal-
uronidase. Hyaluronidases are a key streptococcal virulence factor and are believed to
facilitate bacterial spread within host tissues by breaking down the hyaluronic acid
component of the extracellular matrix (24). Hyaluronidase has also been implicated in
permitting GAS to utilize hyaluronic acids from the host and its own capsule as an
energy source (25). Given that these genes have been strongly implicated in virulence
and in evasion of the host response, we propose that they have driven the emergence
and spread of this invasive emm type in susceptible individuals in this population over
other isolates of GAS. Further characterization of the other genes that were unique to
the emm32.2 isolates but could not be assigned deﬁnitive functions is needed to
evaluate the speciﬁc role of these genes in GAS virulence. The identiﬁcation of these
novel genes not previously characterized in the isolates under investigation clearly
FIG 3 Maximum likelihood phylogeny of the 48 GAS isolates based on core genome SNPs. Each branch is annotated with isolate source followed by the in silico
emm type. R, the GAS reference sequence Streptococcus pyogenes HKU16; C, control iGAS cases; N, control noninvasive isolates; and O, outbreak emm32.2 iGAS
cases. (Middle) Antibiotic resistance and superantigen genes (in gray) in the genomes of the study isolates. (Right) Predicted genomic locations of putative
prophage elements in each study isolate.
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demonstrates the ability of whole-genome sequencing to rapidly generate new re-
search questions surrounding the factors driving the pathogenesis of outbreak clones.
We have shown that in contrast to the majority of other reported iGAS outbreaks in
communities, the emm32.2 outbreak we report is of particular interest as it was not
driven by the acquisition of prophage elements, superantigens, or multidrug resistance,
but rather by the introduction of a novel emm type into the susceptible Liverpool
population. We speculate that the complement of virulence factors that we have
identiﬁed in the emm32.2 outbreak isolates that were not present in other iGAS isolates
circulating in this population during the same time period could have allowed this emm
type to readily disseminate and infect largely immunologically naive individuals within
the population. Clearly, for emm32.2 to have caused iGAS disease over a 3-year period
in the absence of evidence of a direct epidemiological link (i.e., person-to-person), it
must have at least persisted in this population and been carried in other individuals and
may have caused mucosal disease. Therefore, host factors may also play a role. We
present important clinical data that show that an increased odds ratio of emm32.2 iGAS
infection is linked to intravenous drug use, alcohol abuse, and homelessness, suggest-
ing that the clone most readily infects the disadvantaged populations. In an outbreak
of emm59 iGAS reported in speciﬁc regions of Canada, illegal drug use, alcohol abuse,
and homelessness were also all major risk factors for emm59 iGAS (26). Future studies
to cross reference the emm32.2 unique genes to emm59 and other iGAS genotypes
known to cause community outbreaks, predominantly conﬁned to disadvantaged
populations, may establish if these genes are speciﬁc markers of “outbreak” potential.
Outside the United Kingdom, the emm32.2 genotype has only been identiﬁed once
before in 2004 in the blood of a patient with orbito cellulitis in the Czech Republic.
While there are only ﬁve previous reports of ST386 in the pubmlst.org database,
likewise, all of these are from iGAS cases in the Czech Republic identiﬁed between 2003
and 2008. Within the United Kingdom, emm32.2 has only previously been identiﬁed in
isolated cases in Glasgow and Birmingham. It cannot be established from this analysis
how this emm type was introduced into the Liverpool population, although recent
travel did not dictate an increased odds ratio of emm32.2 iGAS.
In summary, we have documented a community outbreak of iGAS in Liverpool that
was caused by the iGAS genotype emm32.2. Comparative genomic analysis of the
outbreak isolates to nonoutbreak isolates has given us a high-resolution view of the
GAS population that is not afforded by conventional molecular typing methods and has
revealed that the ability of the emm32.2 genotype to disseminate in the Liverpool
population was dictated by the presence of 19 genes unique to this outbreak genotype,
including ﬁve genes with well-deﬁned roles in virulence. We propose this subset of
genes allowed emm32.2 iGAS to persist in a disadvantaged population over a 3-year
period.
MATERIALS AND METHODS
Epidemiological investigation. Invasive GAS (iGAS) infection is deﬁned as the isolation of GAS from
normally sterile sites (e.g., blood) or the isolation of GAS from nonsterile sites (e.g., wounds) in the
presence of streptococcal toxic shock syndrome or in the presence of necrotizing fasciitis. In the United
Kingdom, iGAS is a reportable disease (27), with all causative isolates sent to the RVPBRU of PHE for
molecular typing. In September 2012, a notiﬁcation of an iGAS case following hospital admission was
reported in an adult male in Liverpool, Merseyside. The causative isolate typed as emm32.2 using RVPBRU
molecular protocols (https://www.cdc.gov/streplab/m-proteingene-typing.html). At the time, it was
noted that a further two cases of emm32.2 iGAS had been diagnosed at the same hospital in Liverpool
in 2012. An investigation was initiated by PHE to determine whether there were any common exposures
in these cases or the potential for nosocomial infection. All three cases had been community acquired
and admitted with symptoms of sepsis. A review of the RVPBRU typing database identiﬁed that
additional emm32.2 iGAS cases had been reported in the same community since January 2010. From
January 2010 to September 2012, the RVPBRU conﬁrmed a total of 14 cases of emm32.2 iGAS, including
12 residents in Liverpool and two in the wider Merseyside area. No additional emm32.2 iGAS cases have
subsequently been reported in this region. Over the same time period, 30 non-emm32.2 iGAS infections
were reported in Liverpool (Table 1). Case-case analysis was performed using data prospectively collected
for the 12 emm32.2 iGAS outbreak cases and the 30 nonoutbreak iGAS cases reported in Liverpool
residents from information supplied to the public health team (including telephone interviews with
patients) and patient case note reviews. Patients infected with emm32.2 iGAS with illness were desig-
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nated “outbreak cases,” whereas patients infected with non-emm32.2 iGAS were designated “controls.”
Differences in demographic and clinical data between case and controls were assessed by estimating
odd ratios (ORs) using logistic regression analyses. We compared the geographical distributions of
outbreak cases and controls using kernel density estimates (KDE) to smooth the distributions.
Sequencing collection. All 14 emm32.2 outbreak and 15 non-emm32.2 iGAS isolates (randomly
selected from the 30 nonoutbreak iGAS cases available) and a convenience sample of 20 noninvasive
pharyngitis GAS isolates supplied by the Royal Liverpool University Hospitals Trust and Alder Hey
Children’s Hospital were subjected to whole-genome sequencing. The local microbiology laboratories do
not routinely retain noninvasive isolates; therefore, the noninvasive isolates were actively collected
pharyngitis cases diagnosed in Liverpool from June through July 2012, overlapping with the period at
the end of the outbreak. Noninvasive isolates were provided with age (in years) and sex only, without
other clinical details. All GAS isolates were cultured on Columbia horse blood agar (Oxoid, Basingstoke,
United Kingdom) at 37°C with 5% CO2, and DNA was extracted for sequencing using previously described
protocols (28).
Genome sequencing and genotyping. Whole-genome paired-end short reads (100 bp) were
generated using the Illumina Genome Analyzer II (Illumina, Madison, USA) at the Centre for Genomic
Research, University of Liverpool, as previously described (29). In silico emm typing from the short-read
data were performed using a method reported by Athey et al. (30). MLST was determined using the short
read sequence typing tool (SRST) (31). The Illumina sequencing statistics are available for download at
http://cgr.liv.ac.uk/illum/LIMS4128_11dacd433440bef9/.
De novo genome assembly and phylogenetic analysis. De novo genome assembly from short-read
data was performed using Velvet V1.2, with kmer size optimized through VelvetOptimiser (32). The
annotation of assembled genomes was performed using PROKKA (33). The identiﬁed translated open
reading frames (genes) were grouped into orthologous clusters using proteinOrtho4 (34). The sequences
in each orthologous cluster were aligned with PRANK (35) and back-translated into codon alignments.
Orthologous clusters that contained genes from 45 of the 48 study isolates were classed as “core
genes” and concatenated to produce a core genome alignment of all study isolates. A stringent quality
control process was applied to the assembled genomes; however, a relaxed core genome size of45/48
was applied to allow for poor assembly of individual genes, which may have caused the size of the core
genome to be underestimated. All orthologous clusters that contained 45/48 were designated “ac-
cessory genes.” A maximum likelihood phylogeny based on SNPs within the core genome alignment was
reported using RAxML, with 100 random bootstrap replicates (36). Prophages were detected in the
assembled genomes and analyzed using the free web tool PHAST (PHAge Search Tool) (37). Superanti-
gens and antibiotic resistance genes were identiﬁed using the Antibiotic Resistance Identiﬁcation By
Assembly (ARIBA) tool (https://github.com/sanger-pathogens/ariba). A list of the antibiotic resistance
genes used as the input data for ARIBA are available on the comprehensive antibiotic resistance database
(CARD [38]); a list of the superantigens can be found in the report by Spaulding et al. (39). Nucleotide and
translated amino acid sequence of the orthologous gene clusters generated as part of this study are
available for download at https://datahub.io/dataset/liverpool-gas.
Ethics. Ethical approval was not required, as the study was conducted as part of a Health Protection
Agency (now Public Health England) outbreak investigation.
Accession number(s). All of the Illumina sequence reads generated from the study isolates were
deposited in the European Nucleotide Archive under the study accession number PRJEB20045. Individual
accession numbers for short-read data generated from each of the study isolates are listed in Table S1
in the supplemental material.
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